AMLI fusion transcripts in t(3;21) positive leukemia: Evidence of molecular heterogeneity and usage of splicing sites frequently involved in the generation of normal AMLI transcripts
The DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.
Abstract
The t(3;21)(q26;q22) is associated with chronic myelogenous leukemia in blast crisis (CML‐BC), leukemia evolving from (therapy‐related) myelodysplasia, and with leukemia following other hematopoietic proliferate diseases. Molecular cytogenetic analysis and cloning of a few t(3;21) cases indicate that the breakpoints are quite heterogeneous even within a specific clinical phenotype. Interestingly some of the (3;21) breakpoints involve the AMLI gene previously found rearranged in the t(8;21) associated with acute myelogenous leukemia. AMLI is related to the Drosophila gene runt and is the human counterpart of the gene for the α subunit of the nuclear polyoma enhancer binding protein (PEBP2) also known as the core binding factor (CBF). In the t(3;21) AMLI was found rearranged with EAP, a gene on chromosome 3 encoding a small ribosomal protein, as well as with EVII, another gene on chromosome 3. Here we report our study of six cases of t(3;21). By using fluorescence in situ hybridization (FISH) analysis and AMLI probes we could conclude that at least in two CML‐BC cases the breakpoint occurred in the AMLI intron that is disrupted by the t(8;21). An AMLI/EAP fusion transcript, different from the one described in a therapy‐related myelodysplasia, was detected in both CML‐BC cases. This transcript is expected to result in a predicted protein containing the AMLI nuclear binding domain with an attached stretch of 17 amino acids unrelated to the EAP small ribosomal protein. In the other t(3;21) patients we could not detect an AMLI/EAP transcript or an AMLI/EVII transcript. This result suggests heterogeneity of the t(3;21) at the molecular level. The AMLI chimeric transcripts identified so far, both in the t(3;21) and in the t(8;21), diverge from the normal transcripts either after exon 5 or exon 6. Here we show that in normal AMLI transcripts different splicing events are seen to occur after AMLI exon 5 as well as exon 6.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Miyoshi, H., Shimizu, K., Kozu, T., Maseki, N., Kaneko, Y., & Ohki, M. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.23.10431 · Cited by 872
Fusion Between Transcription Factor CBFβ/PEBP2β and a Myosin Heavy Chain in Acute Myeloid Leukemia
Liu, P., Tarlé, S. A., Hajra, A., Claxton, D. F., Marlton, P., Freedman, M., Siciliano, M. J., & Collins, F. S. (1993) · Science · doi:10.1126/science.8351518 · Cited by 732
Erickson, P., Gao, J., Chang, K., Look, T., Whisenant, E., Raimondi, S., Lasher, R., Trujillo, J., Rowley, J., & Drabkin, H. (1992) · Blood · doi:10.1182/blood.v80.7.1825.1825 · Cited by 631
Ogawa, E., Maruyama, M., Kagoshima, H., Inuzuka, M., Lu, J., Satake, M., Shigesada, K., & Ito, Y. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.14.6859 · Cited by 608
Miyoshi, H., Kozu, T., Shimizu, K., Enomoto, K., Maseki, N., Kaneko, Y., Kamada, N., & Ohki, M. (1993) · The EMBO Journal · doi:10.1002/j.1460-2075.1993.tb05933.x · Cited by 498
Wang, S., Wang, Q., Crute, B. E., Melnikova, I. N., Keller, S. R., & Speck, N. A. (1993) · Molecular and Cellular Biology · doi:10.1128/mcb.13.6.3324-3339.1993 · Cited by 435
Downing, Jr., Head, D., Curcio-Brint, A., Hulshof, M., Motroni, T., Raimondi, S., Carroll, A., Drabkin, H., Willman, C., & Theil, K. (1993) · Blood · doi:10.1182/blood.v81.11.2860.2860 · Cited by 173
Nisson, P. E., Watkins, P. C., & Sacchi, N. (1992) · Cancer Genetics and Cytogenetics · doi:10.1016/0165-4608(92)90384-k · Cited by 151
Self-citation
Cited by
Transcription Factors, Normal Myeloid Development, and Leukemia
Tenen, D. G., Hromas, R., Licht, J. D., & Zhang, D.-E. (1997) · Blood · doi:10.1182/blood.v90.2.489 · Cited by 735
AML1 and the 8;21 and 3;21 translocations in acute and chronic myeloid leukemia
Nucifora, G., & Rowley, J. (1995) · Blood · doi:10.1182/blood.v86.1.1.bloodjournal8611 · Cited by 324
The t(12;21) Translocation Converts AML-1B from an Activator to a Repressor of Transcription
Hiebert, S. W., Sun, W., Nathan Davis, J., Golub, T., Shurtleff, S., Buijs, A., Downing, J. R., Grosveld, G., Roussel, M. F., Gary Gilliland, D., et al. (1996) · Molecular and Cellular Biology · doi:10.1128/mcb.16.4.1349 · Cited by 272
Westendorf, J. J., Yamamoto, C. M., Lenny, N., Downing, J. R., Selsted, M. E., & Hiebert, S. W. (1998) · Molecular and Cellular Biology · doi:10.1128/mcb.18.1.322 · Cited by 270
Metadata
- Authors
- Sacchi, N., Nisson, P. E., Watkins, P. C., Faustinella, F., Wijsman, J., & Hagemeijer, A.
- Venue
- Genes, Chromosomes and Cancer
- Publisher
- Wiley
- Published
- 1994-12
- Volume
- 11
- Issue
- 4
- Pages
- 226-236
- ISSN
- 1045-2257 (ISSN-L)
- 1098-2264
- OpenAlex
- W2041662181
- Cited by
- 43
- References
- 8
- FWCI
- 2.81
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: AMLI fusion transcripts in t(3;21) positive leukemia: Evidence of molecular heterogeneity and usage of splicing sites frequently involved in the generation of normal AMLI transcripts. https://app.cochat.ai/papers/10.1002/gcc.2870110405
- The paper
- Sacchi, N., Nisson, P. E., Watkins, P. C., Faustinella, F., Wijsman, J., & Hagemeijer, A. (1994). AMLI fusion transcripts in t(3;21) positive leukemia: Evidence of molecular heterogeneity and usage of splicing sites frequently involved in the generation of normal AMLI transcripts. Genes, Chromosomes and Cancer. https://doi.org/10.1002/gcc.2870110405
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.